Failure to report financial disclosure information

JAMA. 2009 Jan 7;301(1):35-6. doi: 10.1001/jama.2008.905.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Conflict of Interest
  • Disclosure
  • Humans
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal